Fundz

Immunomic Therapeutics reported raising $6.5 Million in an initial SEC Form D filing, from an offering of $16 Million

PRIVATEJun 02, 2025$6.5M of $16M raised

Amount Raised

$6.5 Million

$6.5 Million sold, per SEC Form D (first sale May 29, 2025)

Round Type

Venture

RockvilleBiotechnology

Who to call at Immunomic Therapeutics, Inc., and when

A new round usually means Immunomic Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immunomic Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunomic Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunomic Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunomic Therapeutics, Inc.

Location

ATTN: C. Eric Winze, 15010 BROSCHART RD.

Rockville, Maryland, United States

About

The privately-held biotechnology company is pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors. It has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple solid tumors, including colorectal, pancreatic, mesothelioma, ovarian and breast cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunomic Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts12 people are listed at Immunomic Therapeutics, I…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Immunomic Therapeutics, Inc.'s next move

See what Strategic adds

Immunomic Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.